Institutional Repository of Vilnius University
Triptamino analogų biologinio poveikio vertinimas: elgsena, tolerancija ir farmakokinetika pelėse /
Abstract
dc:descriptionThe prevalence of mental health disorders, especially depression, is continuously increasing worldwide. Traditionally used medications are not always sufficiently effective, often exhibit limited efficacy and are associated with a wide range of adverse side effects. For this reason, it is particularly important to focus on the investigation of new compounds, including tryptamine analogs, which could become alternative means for the effective and safe treatment of mental health disorders. However, before proceeding to clinical trials, it is necessary to thoroughly assess the biological effects, safety, and tolerance of these compounds. The aim of this study is to evaluate the biological effects of new tryptamine analogs (X1, X2, X3, X4), with particular focus on their effects on mouse behavior (locomotor activity, anxiety, psychedelic activity), tolerance and ability to cross blood-brain barrier. The study showed that compounds X1 and X3 significantly reduced locomotor activity in mice, suggesting a possible CNS- suppressive effect, probably via serotonergic 5-HT2C receptors. None of the tested analogs affected the HTR, an indicator of psychedelic effects, which may indicate low activity to 5-HT2A receptors at a dose of 5 mg/kg. In terms of anxiety, the OFT revealed that X1 and X2 have an anxiogenic effect, indicating that their therapeutic potential may be limited due to undesirable effects on anxiety. In contrast, compounds X3 and X4 did not produce anxiety-enhancing effects and demonstrated good safety profile, making them more favorable candidates for further preclinical studies. The key finding is that only compound X3 was detected in mouse brain tissue after intraperitoneal injection, as determined by LC-MS analysis. This indicates that X3 is capable to cross the blood-brain barrier, a property that may underlie its potential activity in the central nervous system and warrants further pharmacological investigation. The results of this study have practical implications for the development of new mental health treatment strategies and contribute to the expansion of scientific knowledge regarding the pharmacological effects and tolerance of structurally modified tryptamine analogs.
Degree
thesis:*- Grantor dc:publisher
- Institutional Repository of Vilnius University
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Zapasnikaitė, Laura,
Rights
dc:rights- Statement dc:rights
-
- info:eu-repo/semantics/openAccess
- Language dc:language
- lit
Identifiers
dc:identifier.*- Repository record dc:identifier
- https://repository.vu.lt/VU:ELABAETD239023355&prefLang=en_US